The World’s Largest Royalty Marketplace

Browse our catalog

Medium length heading goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Investing Update & Analysis
Royalty Sales

Sale of Listerine Royalties Goes For $1.79M

Discover the incredible mouthwash sale that is netting an investor 6 figures per year

Written by
December 2, 2024
5 min
read
read

In this article:

Get started for Free

Create your free account and start listing your music today.

Create your free account and start investing in music today.

Sign Up Free

Imagine earning passive income every time someone buys a bottle of Listerine. This isn’t a fantasy; it’s a reality thanks to royalty investments. Royalty Exchange is a leading online marketplace where you can buy and sell royalties across various asset classes. From iconic music catalogs to unique assets like Listerine sales, Royalty Exchange democratizes access to passive income streams that were once only available to a select few. This blog post analyzes a recent Listerine royalty sale on Royalty Exchange, breaking down the financials, risks, and potential rewards for investors.

What is Royalty Investing?

Royalty investing involves acquiring the right to receive a portion of the ongoing revenue generated by an asset. These assets can range from music copyrights and movie rights to patents and even brand royalties like the Listerine example. When you buy a royalty, you become entitled to a stream of passive income paid out regularly, typically monthly or quarterly.

The Listerine Royalty Sale: A Unique Opportunity

The Royalty Exchange listing for a portion of the Listerine royalties garnered significant interest, attracting 48 offers from 16 different investors. The winning bid of $1,795,000 represented a multiple of 15.71 times the last twelve months' earnings (LTM), highlighting the strong demand for this stable and unique asset.

Why Listerine?

The appeal of the Listerine royalties stems from its remarkable history and contractual strength. The royalty agreement dates back to 1881 and grants a perpetual royalty on global Listerine sales. This agreement's longevity was upheld in a 1959 US federal court ruling, solidifying its legal standing and ensuring continued payments for as long as Listerine is sold.

Financial Performance: A History of Consistent Earnings

The Listerine royalties boast a strong track record of consistent earnings. The listing reported last twelve months' earnings of $114,253, consistent with a three-year average of $114,715. Furthermore, the total earnings since 2009 amount to an impressive $1,354,002, underscoring the long-term value and stability of this asset.

Risk Assessment: Stability and Potential Concerns

The Listerine royalties present a relatively low-risk investment opportunity.

Pros:

  • Globally recognized brand: Listerine is a household name with a history spanning over a century, suggesting continued sales and royalty payments.
  • Legally protected: The royalty agreement's perpetual nature is legally binding and has withstood legal challenges.
  • Diversification: Listerine's presence in the consumer staples sector provides a hedge against economic downturns as demand for essential products like mouthwash remains relatively stable.

Cons:

  • Market competition: While Listerine is a leading brand, competition from other mouthwash brands could impact future sales and royalty payments.
  • Changing consumer preferences: Shifts in consumer preferences towards natural or alternative oral care products could potentially affect Listerine's market share in the long run.

Bidding History: Strong Investor Appetite

The auction's bidding history reveals a fiercely competitive landscape with investors eager to acquire this unique asset. The final sale price was reached after a series of counteroffers and rejected bids. This intense bidding activity demonstrates the high demand for stable and predictable passive income streams, particularly in uncertain economic times.

Why the Winning Bidder May Have Found This Attractive

The winning bidder likely viewed the Listerine royalties as a compelling long-term investment due to its stable income stream, contractual security, and brand recognition. The 15.71x LTM multiple paid for the asset suggests the bidder expects continued growth and consistent returns for years to come.

Get Started with Royalty Investing

Royalty Exchange offers a unique platform for individuals to participate in royalty investing, opening up a world of passive income opportunities previously accessible only to institutional investors. The platform features a diverse range of assets with some going for as little as hundreds of dollars to ones like this which fetch millions of dollars. Some of the most notable artists in the world have song royalties available on Royalty Exchange, with music catalogs by renowned artists like Jay-Z, Jimi Hendrix, Dire Straits, and Ariana Grande to other unique royalty streams.

Creating an account on Royalty Exchange is easy and provides access to thousands of exciting royalty investment opportunities. By browsing active listings, reviewing financial data, and participating in auctions, new investors can explore the potential of royalty investing to diversify their portfolios and generate passive income. On Royalty Exchange you can sign up as an investor and search through thousands of music catalog listings that include producer and songwriter royalties to some of the biggest songs of the past few decades. Discover why song royalties are one of the best investments to grow your wealth in 2024 and download the free Ultimate Guide To Music Royalties to learn everything you need to know about investing in royalties. Invest in music today and reap the benefits of earning passive income from music rights whose value is independent of macroeconomic markets.

Get the latest deals straight to your inbox.

Sign up to get notified of every new deal that comes on the exchange.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.